Skip to main content

Table 1 The general clinical characteristics of the included patients

From: Relationship between efficacy and common metabolic parameters in first-treatment drug-naïve patients with early non-response schizophrenia: a retrospective study

Index

Included patients (n = 143)

Age—years

 Mean (SD)

29.37 (7.30)

 Range

18–45

Gender—(n, %)

 Female

80, 55.94%

 Male

63, 44.06%

 Onset age

24.41 (6.53)

 Course of disease

2.97 (1.79)

Marital status—(n, %)

 Unmarried

63, 44.06%

 Married

66, 46.15%

 Divorced

14, 9.79%

Living condition—(n, %)

 With spouse

62, 43.36%

 With parents

78, 54.54%

 Live alone

3, 2.10%

Educational background—(n, %)

 Bachelor degree

7, 4.90%

 College degree

8, 5.59%

 Secondary specialized and high school

36, 25.17%

 Junior high school

69, 48.25%

 Primary school

22, 15.38%

 Illiteracy

1, 0.7%

Family history

 Positive

35, 24.48%

 Negative

108, 75.52%

Prescription drugs—(n, %)

 Aripiprazole

24, 16.78%

 Olanzapine

27, 18.88%

 Quetiapine

22, 15.38%

 Risperidone

28, 19.58%

 Ziprasidone

21, 14.69%

 Perphenazine

9, 6.29%

 Haloperidol

12, 8.39%